Victory Capital Management
OMIC

Victory Capital Management’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Victory Capital Management’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,024
Closed -$152K – 2736
2022
Q3 		$152K Sell
2,024
-3,810
-65% -$398K ﹤0.01% 2402
2022
Q2 		$669K Buy
5,834
+9
+0.2% +$1.06K ﹤0.01% 1936
2022
Q1 		$966K Sell
5,825
-159
-3% -$36.8K ﹤0.01% 1834
2021
Q4 		$2.08M Sell
5,984
-694
-10% -$269K ﹤0.01% 1542
2021
Q3 		$2.24M Buy
6,678
+107
+2% +$54.9K ﹤0.01% 1564
2021
Q2 		$5.42M Buy
+6,571
New +$5.09M 0.01% 1314

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management's OMIC Position: Q4 2022 in Review

Victory Capital Management sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q4 2022, closing a stake of 2,024 shares — an estimated $152K sold.

Victory Capital Management first reported a position in OMIC in Q2 2021 and held it in 6 quarters. The position peaked at $5.42M in Q2 2021. 80 funds tracked by Wall St. Rank hold OMIC as of Q4 2022.

  • Victory Capital Management reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Victory Capital Management sold 2,024 Singular Genomics Systems, Inc. Common Stock shares in Q4 2022, an estimated $152K.
  • Victory Capital Management first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • Victory Capital Management's Singular Genomics Systems, Inc. Common Stock position peaked at $5.42M in Q2 2021.
  • 80 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q4 2022.

Based on Victory Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.